Your browser doesn't support javascript.
loading
The association between the HLA-G 14-bp insertion/deletion polymorphism and type 1 diabetes.
Silva, H P V; Ururahy, M A G; Souza, K S C; Loureiro, M B; Oliveira, Y M C; Oliveira, G H M; Luchessi, A D; Carvalho, K T C; Freitas, J C O C; Donadi, E A; Hirata, R D C; Almeida, M G; Arrais, R F; Hirata, M H; Rezende, A A.
Afiliação
  • Silva HP; Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.
  • Ururahy MA; Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.
  • Souza KS; Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.
  • Loureiro MB; Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.
  • Oliveira YM; Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.
  • Oliveira GH; Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.
  • Luchessi AD; Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.
  • Carvalho KT; Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.
  • Freitas JC; Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.
  • Donadi EA; Department of Clinical and Toxicological Analyses, University of Sao Paulo, Sao Paulo, Brazil.
  • Hirata RD; Division of Clinical Immunology, Department of Medicine, School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil.
  • Almeida MG; Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.
  • Arrais RF; Pediatrics Endocrinology Unit, Federal University of Rio Grande do Norte, Natal, Brazil.
  • Hirata MH; Division of Clinical Immunology, Department of Medicine, School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil.
  • Rezende AA; Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.
Genes Immun ; 17(1): 13-8, 2016.
Article em En | MEDLINE | ID: mdl-26492519
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Predisposição Genética para Doença / Diabetes Mellitus Tipo 1 / Antígenos HLA-G Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Child / Female / Humans / Male País como assunto: America do sul / Brasil Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Predisposição Genética para Doença / Diabetes Mellitus Tipo 1 / Antígenos HLA-G Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Child / Female / Humans / Male País como assunto: America do sul / Brasil Idioma: En Ano de publicação: 2016 Tipo de documento: Article